Biotech / Pharma
AdvanCell
Biotech / Pharma
AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, received a $315 million Series D led by Ally Bridge Group and Alpha Wave.
Founded
Region